References
- Anh, D. D., D. G. Canh, A. L. Lopez, V. D. Thiem, P. T. Long, H. H. Son, et al. 2007. Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults. Vaccine 25: 1149-1155 https://doi.org/10.1016/j.vaccine.2006.09.049
- Clemens, J., D. A. Sack, J. R. Harris, F. van Loon, J. Chakraborty, F. Ahmed, et al. 1990. Field trial of oral cholera vaccine in Bangladesh: Results from three-year follow-up. Lancet 335: 270-273 https://doi.org/10.1016/0140-6736(90)90080-O
- Cuatrecasas, P. 1973. Vibrio cholerae choleragenoid. Mechanism of inhibition of cholera toxin action. Biochemistry 15: 3577-3781 https://doi.org/10.1021/bi00742a034
- Dawson, R. M. 2005. Characterization of the binding of cholera toxin to ganglioside GM1 immobilized onto microtitre plates. J. Appl. Toxicol. 25: 30-38 https://doi.org/10.1002/jat.1015
- Gill, D. M. 1976. The arrangement of subunits in cholera toxin. Biochemistry 15: 1242-1248 https://doi.org/10.1021/bi00651a011
- Girard, M. P., D. Steele, C.-L. Chaignat, and M. P. Kieny. 2006. A review of vaccine research and development: Human enteric infections. Vaccine 24: 2732-2750 https://doi.org/10.1016/j.vaccine.2005.10.014
- Holmgren, J. 1981. Action of cholera toxin and the prevention and treatment of cholera. Nature 292: 413-417 https://doi.org/10.1038/292413a0
- Holmgren, J. 1973. Comparison of the tissue receptors for Vibrio cholerae and Escherichia coli enterotoxins by means of gangliosides and natural cholera toxoid. Infect. Immun. 8: 851-859
- Holmgren, J. and A. M. Svennerholm. 1973. Enzyme-linked immunosorbent assays for cholera serology. Infect. Immun. 7:759-763
- Kurosky, A., D. E. Markel, B. Touchstone, and J. W. Peterson. 1976. Chemical characterization of the structure of cholera toxin and its natural toxoid. J. Infect. Dis. 133(Suppl): S14-S24 https://doi.org/10.1093/infdis/133.Supplement_1.S14
- Laurell, C.-B. 1966. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal. Biochemis. 15: 45-52 https://doi.org/10.1016/0003-2697(66)90246-6
- Lonnroth, I. and J. Holmgren. 1973. Subunit structure of cholera toxin. J. Gen. Microbiol. 76: 417-427 https://doi.org/10.1099/00221287-76-2-417
- Lowry, O. H., N. J. Rosebrough, A. C. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275
- Mekalanos, J. J., R. J. Collier, and W. R. Romig. 1978. Purification of cholera toxin and its subunits: New methods of preparation and the use of hypertoxinogenic mutants. Infect. Immun. 20: 552-558
- Mekalanos, J. J. 1988. Production and purification of cholera toxin. Methods Enzymol. 165: 169-175 https://doi.org/10.1016/S0076-6879(88)65027-0
- Osek, J., M. Lebens, and J. Holmgren.1995. Improved medium for large-scale production of recombinant cholera toxin B subunit for vaccine purposes. J. Microbiol. Methods 24: 117-123 https://doi.org/10.1016/0167-7012(95)00061-5
- Rappaport, R. S., B. A. Rubin, and H. Tint. 1974. Development of a purified cholera toxoid. I. Purification of toxin. Infect. Immun. 9: pp. 294-303
- Slos, P., D. Speck, N. Accart, H. V. J. Kolbe, D. Schubnel, B. Bouchon, R. Bischoff, and M. P. Kieny. 1994. Recombinant cholera toxin B-subunit in Escherichia coli: High-level secretion, purification, and characterization. Protein Express. Purif. 5:518-526 https://doi.org/10.1006/prep.1994.1071
-
Tayot, J.-L., J. Holmgren, L. Svennerholm, M. Lindblad, and M. Tardy. 1981. Receptor-specific large-scale purification of cholera toxin on silica beads derivatized with
$lysoG_{M1}$ ganglioside. Eur. J. Biochem. 113: 249-258 https://doi.org/10.1111/j.1432-1033.1981.tb05060.x -
Turnbull, P. C., J. V. Lee, M. D. Miliotis, C. S. Still, M. Isa
$\ddot{a}$ cson, and Q. S. Ahmad. 1985. In vitro and in vivo cholera toxin production by classical and El Tor isolates of Vibrio cholerae. J. Clin. Microbiol. 21: 884-890 - Walker, R. I. 2005. Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries. Vaccine 23: 3369-3385 https://doi.org/10.1016/j.vaccine.2004.12.029
- WHO Expert Committee on Biological Standardization. 2004. WHO Technical Report, Series No. 924